hrp0094fc6.4 | Bone and Mineral Metabolism | ESPE2021

Use of Aids, Assistive Devices and Adaptations (AADAs) by Individuals Aged <25 Years with Fibrodysplasia Ossificans Progressiva (FOP): 36-Month Results from a Global Natural History Study (NHS)

Hsiao Edward C. , Pignolo Robert J. , Baujat Genevieve , Brown Matthew A. , De Cunto Carmen , Keen Richard , Mukaddam Mona Al , Marino Rose , Houchard Aude , Kaplan Frederick S. ,

Background: Individuals with the ultra-rare genetic disorder FOP experience progressive heterotopic ossification. Median age at diagnosis is 5 years; patients are supported by multiple specialties. Most patients become immobilised by the third decade of life, requiring lifelong assistance. We characterise AADA use as an indicator of disease severity in younger individuals with FOP enrolled in a 36-month, prospective, global NHS (NCT02322255).<p class="abst...

hrp0094p1-51 | Bone B | ESPE2021

A Global Natural History Study (NHS) of Fibrodysplasia Ossificans Progressiva (FOP): Normal Long Bone Growth and Abnormalities in Younger Patients over 36 Months

Pignolo Robert J. , Baujat Genevieve , Brown Matthew A. , Cunto Carmen De , Hsiao Edward C. , Keen Richard , Mukaddam Mona Al , Marino Rose , Houchard Aude , Kaplan Frederick S. ,

Background: FOP is an ultra-rare, severely disabling genetic disorder characterised by progressive heterotopic ossification. The median age at diagnosis is 5 years and patients are supported by multiple specialties. We describe normal long bone growth changes and incidence of bone abnormalities in participants with FOP aged <18 years in a 3-year, prospective, global NHS (NCT02322255).Methods: Individuals with FOP age...

hrp0094p2-278 | Growth and syndromes (to include Turner syndrome) | ESPE2021

Effects of growth hormone therapy on serum concentrations of IGF-1 in patients with Turner syndrome: High IGF-1 concentrations despite optimal dose?

Karakilic Ozturan Esin , Karagoz Nurinisa , Ceylaner Serdar , Pinar Ozturk Ayse , Derya Kardelen Al Aslı , Yavas Abali Zehra , Poyrazoglu Sukran , Bas Firdevs , Darendeliler Feyza ,

Introduction: Growth hormone (GH) treatment is used to accelerate growth in patients with Turner syndrome (TS). During treatment, evaluation of IGF-1 is strongly recommended for efficacy and safety. Some patients, despite optimum GH doses, have persistent high IGF-1 levels. In this study, we aimed to evaluate the relationship between IGF-1 levels, IGF1R and growth responses of TS patients on GH treatment.Method: 54 patie...

hrp0097p1-126 | Growth and Syndromes | ESPE2023

A Rare Coexistence of Turner Syndrome and Mycosis Fungoides: A Case Report

Bayrak Demirel Özge , Karakılıç Özturan Esin , Derya Kardelen Al Aslı , Yıldız Melek , Poyrazoğlu Şükran , Baş Firdevs , Darendeliler Feyza

Introduction: The frequency of solid and hematological malignancies has been reported to be higher in children with Turner syndrome than in the general population. Mycosis fungoides (MF) represent the most common type of cutaneous T-cell lymphoma, which is a low-grade lymphoproliferative disease. To the best of our knowledge, the coexistence of Turner syndrome and MF has not yet been reported. Here, we report a girl with Turner syndrome and MF.<p class="ab...

hrp0097p2-79 | Adrenals and HPA Axis | ESPE2023

Final Adult Height in Saudi patients with Congenital Adrenal Hyperplasia

Al Alwan Ibrahim , Shafaay Edi , Aldriweesh Mohammed , Aljahdali Ghadeer , Alomar Abdulrahman , Alharbi Khulood , Aldalaan Haneen , Alenazi Ahmed , Alsagheir Afaf , S. Alangari Abdulaziz , Babiker Amir

Introduction: Congenital Adrenal Hyperplasia (CAH) is a chronic disease that requires life-long hormonal replacement therapy. Growth of patients with CAH can be affected by this therapy or the hyperandrogenic effect of the disease. In this study, we aimed to assess the potential effect of CAH and its therapy on final height in Saudi affected patients.Methodology: This is a retrospective cohort study from two tertiary end...

hrp0098fc13.1 | Pituitary, Neuroendocrinology and Puberty 2 | ESPE2024

Defect in C-terminal alpha-amidation during Kisspeptin synthesis: a new mechanism of hypogonadotropic hypogonadism

Hung NGuyen Viet , Al Amir Ahmad Issam , Ben Rhaiem Ines , Maugenre Svetlana , Leprince Jérome , Carel Jeaan-Claude , de Roux Nicolas

The synthesis of many peptides involves several post-translational steps which converts precursors into bioactive peptide. One of these steps results in the α-amidation of the C-terminal from a glycine through a bifunctional enzyme called the peptidylglycine α-amidating monooxygenase (PAM). Although the physiological role of Kisspeptin (KP) in the control of GnRH secretion is well known, the exact molecular form of the bioactive hypothalamic KP remains elusive. By ...

hrp0098fc14.1 | Fetal and Neonatal Endocrinology | ESPE2024

Non-invasive prenatal testing can detect maternally and paternally inherited variants in the KCNJ11 and ABCC8 genes: implications for clinical management of neonatal diabetes during pregnancy and beyond

Bowman Pamela , de Franco Elisa , Philpott Natasha , M Gurnell Eleanor , Iotova Violeta , Gaal Zsolt , Howard-James Naomi , Cody Declan , E Flanagan Sarah , T Hattersley Andrew , AL Houghton Jayne

Introduction/Background: Non-invasive prenatal testing (NIPT) represents a major development for families affected by rare monogenic conditions by facilitating early prenatal diagnosis without the risks associated with traditional more invasive methods. For most rare diseases NIPT is only available clinically for paternally-inherited variants. One exception is in GCK and HNF4A diabetes, where the detection of a maternally or paternally inheri...

hrp0098t12 | Top 20 Posters | ESPE2024

Investigating the Effects of Familial Mediterranean Fever on Growth and Puberty: Does the Duration of Puberty Change?

Bayrak Demirel Ozge , Duygu Arik Selen , Kandemir Tugce , Akgun Ozlem , Derya Kardelen Al Asli , Yildiz Melek , Poyrazoglu Sukran , Aktay Ayaz Nuray , Bas Firdevs , Darendeliler Feyza

Background: Familial Mediterranean Fever (FMF) is the most common hereditary periodic fever syndrome in Turkey. The effects of FMF on growth and puberty characteristics have yet to be investigated. This study aims to describe the features of children with FMF in terms of growth and puberty and compare them with healthy children.Methods: This retrospective study analyzed the clinical and laboratory records of 140 FMF-diag...

hrp0098p1-35 | Diabetes and Insulin 2 | ESPE2024

Diabetes Mellitus in Woodhouse -Sakati syndrome

Amin Rasha , Khalifa Amel , Petrovski Goran , Mohammed Elwaseila , Dauleh Hajar , Haris Basma , Chirayath Shiga , Mohamadsalih Ghassan , Al Bureshad Khalid , Ibrahim Marwa , Hussain Khalid

Background: Woodhouse-Sakati syndrome (WSS) is a rare, autosomal recessive genetic disorder with variable clinical manifestations mainly affecting the endocrine and nervous systems. Diabetes mellitus is one endocrine manifestation but there are no comprehensive data on the epidemiology, clinical features, underlying mechanisms, and management, particularly within the Qatari population.Methods: This retrospective study wa...

hrp0098p1-146 | Fat, Metabolism and Obesity 3 | ESPE2024

Evaluation of microvascular abnormalities and metabolic status in children with non-syndromic early-onset severe obesity using nailfold capillaroscopy

Tercan Ummahan , Akgun Ozlem , Kandemir Tugce , Derya Kardelen Al Asli , Yildiz Melek , Poyrazoglu Sükran , Bas Firdevs , Aktay Ayaz Nuray , Darendeliler Feyza

Background: In early-onset obesity, metabolic and cardiovascular problems like insulin resistance, hypertension, dyslipidemia, and metabolic syndrome start early in life. Our study aimed to investigate the relationship between metabolic and microvascular abnormalities in children with early-onset severe obesity using a non-invasive method, nailfold video capillaroscopy (NVC).Methods: In this cross-sectional study, 27 pat...